We were interested whether ML-1 containing drugs like the fermented extract ISCADOR Qu or pure ML-1 preparations like recombinant ML-1 (Aviscumine) or native ML-1 could be used as adjuvant therapeutics to treat GBM. This evidence concerns the gene ATP8A2 and glioblastoma.